HQL
$13.82
abrdn Life Sciences Investors
Fund Family: abrdn Life Sciences Investors
1 Month
+3.91%
YTD
-2.77%
1 Year
-2.77%
3 Year
+25.44%
Top 10 Holdings (42.7% of portfolio)
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Regeneron Pharmaceuticals Inc | REGN | Manufacturing | 7.35% |
| 2 | Amgen Inc | AMGN | Manufacturing | 7.28% |
| 3 | Gilead Sciences Inc | GILD | Manufacturing | 6.61% |
| 4 | Vertex Pharmaceuticals Inc | VRTX | Manufacturing | 4.53% |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | Manufacturing | 3.45% |
| 6 | BioMarin Pharmaceutical Inc | BMRN | Manufacturing | 3.44% |
| 7 | State Street Institutional US Government Money Market Fund | GVMXX | Unknown | 2.92% |
| 8 | Insmed Inc | IM8N | Unknown | 2.42% |
| 9 | ARGENX SE | ARGX | Manufacturing | 2.41% |
| 10 | BioNTech SE | BNTX | Manufacturing | 2.34% |
Fund Information
| Net Assets | $395.93M | Expense Ratio | N/A |
| Total Holdings | 96 | Annual Fee* | N/A |
| Inception Date | N/A | Fund Family | abrdn Life Sciences Investors |
*Annual fee per $10,000 invested